Phantom criteria for qualification of brain FDG and amyloid PET across different cameras.

Ikari, Yasuhiko; Akamatsu, Go; Nishio, Tomoyuki; Ishii, Kenji; Ito, Kengo; Iwatsubo, Takeshi; Senda, Michio

Ikari, Yasuhiko; Akamatsu, Go; Nishio, Tomoyuki; Ishii, Kenji; Ito, Kengo; Iwatsubo, Takeshi; Senda, Michio.

Affiliation

Ikari Y; Division of Molecular Imaging, Institute of Biomedical Research and Innovation, 2-2, Minatojima-Minamimachi, Chuo-ku, Kobe, 650-0047, Japan. ikari@fbri.org.
Akamatsu G; Division of Molecular Imaging, Institute of Biomedical Research and Innovation, 2-2, Minatojima-Minamimachi, Chuo-ku, Kobe, 650-0047, Japan.
Nishio T; Division of Molecular Imaging, Institute of Biomedical Research and Innovation, 2-2, Minatojima-Minamimachi, Chuo-ku, Kobe, 650-0047, Japan.
Ishii K; Research Team for Neuroimaging, Tokyo Metropolitan Institute of Gerontology, Tokyo, Japan.
Ito K; Department of Clinical and Experimental Neuroimaging, National Center for Geriatrics and Gerontology, Obu, Japan.
Iwatsubo T; Department of Neuropathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Senda M; Division of Molecular Imaging, Institute of Biomedical Research and Innovation, 2-2, Minatojima-Minamimachi, Chuo-ku, Kobe, 650-0047, Japan. senda@fbri.org.

EJNMMI Phys ; 3(1): 23, 2016 Dec.

Article de En | MEDLINE | ID: mdl-27709546

Mots clés

Amyloid PET; Brain FDG-PET; Image quality; Multicenter study; Standardization

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Clinical_trials / Guideline / Prognostic_studies Langue: En Journal: EJNMMI Phys Année: 2016 Type de document: Article Pays d'affiliation: Japon

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google